(S)-nicotine increases expression ISO RGD:1317196 6480464 Nicotine results in increased expression of IGSF3 mRNA CTD PMID:23825647 17beta-estradiol multiple interactions ISO RGD:1317196 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGSF3 mRNA CTD PMID:19619570 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IGSF3 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1317196 6480464 Estradiol results in increased expression of IGSF3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317196 6480464 Tetrachlorodibenzodioxin results in increased expression of IGSF3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGSF3 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IGSF3 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGSF3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317196 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGSF3 mRNA CTD PMID:19619570 2-hydroxypropanoic acid increases expression ISO RGD:1317196 6480464 Lactic Acid results in increased expression of IGSF3 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane increases expression ISO RGD:1307796 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IGSF3 mRNA CTD PMID:30723492 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of IGSF3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1317196 6480464 Decitabine affects the expression of IGSF3 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression ISO RGD:1307796 6480464 Propylthiouracil results in increased expression of IGSF3 mRNA CTD PMID:24780913 afimoxifene multiple interactions ISO RGD:1317196 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of IGSF3 mRNA] CTD PMID:21233418 antirheumatic drug increases expression ISO RGD:1317196 6480464 Antirheumatic Agents results in increased expression of IGSF3 mRNA CTD PMID:24449571 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 beta-hexachlorocyclohexane increases expression EXP 6480464 beta-hexachlorocyclohexane results in increased expression of IGSF3 mRNA CTD PMID:25270620 bisphenol A affects expression ISO RGD:1307796 6480464 bisphenol A affects the expression of IGSF3 mRNA CTD PMID:25181051 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of IGSF3 promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:1317196 6480464 bisphenol A results in decreased expression of IGSF3 mRNA CTD PMID:27685785 butanal decreases expression ISO RGD:1317196 6480464 butyraldehyde results in decreased expression of IGSF3 mRNA CTD PMID:26079696 C60 fullerene decreases expression ISO RGD:1307796 6480464 fullerene C60 results in decreased expression of IGSF3 mRNA CTD PMID:19167457 calcitriol increases expression ISO RGD:1317196 6480464 Calcitriol results in increased expression of IGSF3 mRNA CTD PMID:26485663 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of IGSF3 mRNA CTD PMID:25554681 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of IGSF3 mRNA CTD PMID:28472532 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 cisplatin increases expression ISO RGD:1307796 6480464 Cisplatin results in increased expression of IGSF3 mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:1317196 6480464 Cisplatin affects the expression of IGSF3 mRNA CTD PMID:23300844 cyclosporin A increases methylation ISO RGD:1317196 6480464 Cyclosporine results in increased methylation of IGSF3 promoter CTD PMID:27989131 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of IGSF3 mRNA CTD PMID:22733784 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of IGSF3 mRNA CTD PMID:24205000 dioxygen affects methylation EXP 6480464 Oxygen deficiency affects the methylation of IGSF3 promoter CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1317196 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1317196 6480464 Doxorubicin results in decreased expression of IGSF3 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:1307796 6480464 Endosulfan results in decreased expression of IGSF3 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of IGSF3 mRNA CTD PMID:30319688 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IGSF3 mRNA CTD PMID:28329830 furan increases expression ISO RGD:1307796 6480464 furan results in increased expression of IGSF3 mRNA CTD PMID:27387713 leflunomide decreases expression ISO RGD:1317196 6480464 leflunomide results in decreased expression of IGSF3 mRNA CTD PMID:28988120 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of IGSF3 mRNA CTD PMID:18502557 methylseleninic acid affects expression ISO RGD:1317196 6480464 methylselenic acid affects the expression of IGSF3 mRNA CTD PMID:14617803 nicotine increases expression ISO RGD:1317196 6480464 Nicotine results in increased expression of IGSF3 mRNA CTD PMID:23825647 oxaliplatin multiple interactions ISO RGD:1307796 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGSF3 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:1307796 6480464 oxaliplatin results in increased expression of IGSF3 mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IGSF3 mRNA CTD PMID:17562736 rac-lactic acid increases expression ISO RGD:1317196 6480464 Lactic Acid results in increased expression of IGSF3 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1317196 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGSF3 mRNA CTD PMID:21641980 tebuconazole decreases expression ISO RGD:1317196 6480464 tebuconazole results in decreased expression of IGSF3 mRNA CTD PMID:30458266 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of IGSF3 mRNA CTD PMID:17484886 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of IGSF3 mRNA CTD PMID:23557971 topotecan increases expression ISO RGD:1307796 6480464 Topotecan results in increased expression of IGSF3 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1307796 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGSF3 mRNA CTD PMID:25729387 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGSF3 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1317196 6480464 Valproic Acid results in increased expression of IGSF3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1317196 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1317196 6480464 Valproic Acid affects the expression of IGSF3 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1317196 6480464 Valproic Acid results in decreased methylation of IGSF3 gene CTD PMID:29154799 vinclozolin decreases expression ISO RGD:1307796 6480464 vinclozolin results in decreased expression of IGSF3 mRNA CTD PMID:23034163
Gene-Chemical Interaction Annotations
